↓ Skip to main content

Activating transcription factor-2 (ATF2) is a key determinant of resistance to endocrine treatment in an in vitro model of breast cancer

Overview of attention for article published in Breast Cancer Research, November 2020
Altmetric Badge

Readers on

mendeley
24 Mendeley
You are seeing a free-to-access but limited selection of the activity Altmetric has collected about this research output. Click here to find out more.
Title
Activating transcription factor-2 (ATF2) is a key determinant of resistance to endocrine treatment in an in vitro model of breast cancer
Published in
Breast Cancer Research, November 2020
DOI 10.1186/s13058-020-01359-7
Pubmed ID
Authors

Athina Giannoudis, Mohammed Imad Malki, Bharath Rudraraju, Hisham Mohhamed, Suraj Menon, Triantafillos Liloglou, Simak Ali, Jason S. Carroll, Carlo Palmieri

Mendeley readers

Mendeley readers

The data shown below were compiled from readership statistics for 24 Mendeley readers of this research output. Click here to see the associated Mendeley record.

Geographical breakdown

Country Count As %
Unknown 24 100%

Demographic breakdown

Readers by professional status Count As %
Student > Bachelor 4 17%
Student > Doctoral Student 2 8%
Student > Master 2 8%
Researcher 2 8%
Student > Ph. D. Student 2 8%
Other 3 13%
Unknown 9 38%
Readers by discipline Count As %
Biochemistry, Genetics and Molecular Biology 6 25%
Medicine and Dentistry 3 13%
Agricultural and Biological Sciences 2 8%
Arts and Humanities 1 4%
Earth and Planetary Sciences 1 4%
Other 1 4%
Unknown 10 42%